NEXIS试验:床旁骑行联合静脉氨基酸对急性呼吸衰竭患者的随机试验
NEXIS是一项多中心2期随机试验,纳入115例急性呼吸衰竭患者(中位年龄约55岁,55%男性,APACHE II约24,>90%机械通气),1:1随机分配至方案化床旁骑行(45分钟/日)联合静脉氨基酸(总蛋白摄入2.0-2.5 g/kg/d)加常规治疗组或单独常规治疗组。主要终点为出院时盲法评估的6分钟步行距离(6MWD)。中位差10米,95%CI -75至84)。次要结局(ICU和出院时功能指标及6个月电话随访)两组亦相似。因招募缓慢提前终止,未见安全性问题。
要点
- 干预方案为床旁骑行45分钟/日联合静脉氨基酸使总蛋白摄入达2.0-2.5 g/kg/d;实际干预组骑行40±7分钟/日,总蛋白摄入1.9±0.6 g/kg/d,对照组0.9±0.6 g/kg/d。
- 干预组与对照组在ICU和出院时功能指标及6个月电话随访的次要结局均相似。
- 该联合干预在急性呼吸衰竭患者中 appear safe,未见安全性问题,但因招募缓慢提前终止。
- 研究为2期试验,计划样本量128例可评估患者(每组64例),实际随机115例(干预组60例,对照组55例)。
适用人群与场景
- ICU内急性呼吸衰竭(ARF)患者,中位年龄约55岁,55%男性,APACHE II约24,>90%机械通气。
- 多中心2期随机试验,纳入标准为ICU内急性呼吸衰竭;排除标准原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 干预组:方案化床旁骑行45分钟/日联合静脉氨基酸,使总蛋白摄入达2.0-2.5 g/kg/d,加常规治疗;实际骑行40±7分钟/日,总蛋白摄入1.9±0.6 g/kg/d。
- 对照组:仅常规治疗,实际总蛋白摄入0.9±0.6 g/kg/d。
- 主要终点为出院时盲法评估的6分钟步行距离(6MWD)。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 多中心2期随机试验,115例患者随机(干预组60例,对照组55例),计划样本量128例可评估患者(每组64例),因招募缓慢提前终止,未见安全性问题。
- 次要结局:ICU和出院时功能指标及6个月电话随访两组相似。
- 干预实际执行:骑行40±7分钟/日(对照组0分钟/日),总蛋白摄入1.9±0.6 g/kg/d(对照组0.9±0.6 g/kg/d)。
证据类型、等级与局限
- 证据类型:多中心2期随机对照试验(RCT),意向性分析(intention to treat),盲法评估主要终点。
- 局限:因招募缓慢提前终止,实际样本量小于计划(115例 vs 计划128例可评估);原文未给出证据等级或推荐强度。
对床旁实践的改变
- 对于ICU内急性呼吸衰竭患者,早期床旁骑行联合静脉氨基酸补充(总蛋白2.0-2.5 g/kg/d) appear safe,但不应期望其改善出院时6MWD或住院期间及6个月随访的次要功能结局。
- 该干预方案在急性呼吸衰竭患者中未显示功能获益,临床决策时应考虑其他策略;原文未提及其他适用或不适用人群。
指南或共识出处
- NEXIS trial: Nutrition and Exercise in Critical Illness Trial, ClinicalTrials.gov (NCT03021902); 发表于Am J Respir Crit Care Med。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: Patients with acute respiratory failure (ARF) in intensive care units (ICUs) often experience immobility and limited nutritional intake, with long-lasting impairments.
OBJECTIVE: Evaluate whether combined in-bed cycling exercise and intravenous amino acid, initiated early in the ICU, improves physical functioning.
METHODS: This multicenter phase 2 trial randomly allocated patients 1:1 to protocolized in-bed cycling (45 min/d) plus intravenous amino acid (total protein intake: 2.0-2.5 g/kg/d) plus usual care vs usual care alone. Blinded assessment of 6-minute walk distance (6MWD) at hospital discharge was the primary outcome. Secondary outcomes included functional measures at ICU and hospital discharge, along with phone surveys at the 6-month follow-up. Patients were analyzed according to intention to treat. The planned sample size was 128 evaluable patients (64 per arm).
MEASUREMENTS AND MAIN RESULTS: In total, 115 patients (median age ∼55 years, 55% male, Acute Physiology and Chronic Health Evaluation II ∼24, >90% mechanically ventilated) were randomized (60 intervention; 55 control). Enrollment was stopped early due to slow recruitment, with no evidence of safety concerns. The mean duration of cycling was 40 ± 7 min/d (control: 0 min/d), with total protein intake of 1.9 ± 0.6 g/kg/d (control: 0.9 ± 0.6). The median (interquartile range) 6MWD was similar between intervention and control: 108 (15-242) and 95 (0-196) m (P = .51) (median difference, 10; 95% CI, -75 to 84). Secondary outcomes were also similar between groups.
CONCLUSION: Among patients with ARF, a combined intervention of early in-bed cycling and amino acid supplementation appeared safe but did not improve 6MWD or secondary outcomes during hospitalization or 6-month follow-up. Clinicaltrials.gov (NCT03021902).
参考来源
- Needham DM, Files DC, Hough CL, et al. Nutrition and Exercise in Critical Illness (NEXIS) trial: randomized trial of combined in-bed cycling and intravenous amino acid plus usual care. Am J Respir Crit Care Med. 2026. PMID: 42438140. doi:10.1093/ajrccm/aamag287
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。